Heron Therapeutics, Inc. (HRTX) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Heron Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.377 Thank you for standing by and welcome to the Huron Therapeutics Second Quarter 2025 Earnings 00:00:05.377 -- 00:00:10.342 Conference Call. At this time, all participants are in a listen-only mode. 00:00:10.342 -- 00:00:13.926 After the speaker's presentation, there will be a question and answer session. 00:00:13.926 -- 00:00:19.032 To ask a question during this session, you'll need to press star 1-1 on your telephone. 00:00:19.032 -- 00:00:22.556 If your question has been answered and you'd like to remove yourself from the queue, 00:00:22.556 -- 00:00:28.546 simply press star 1-1 again. As a reminder, today's program is being recorded. 00:00:28.546 -- 00:00:33.731 And now I'd like to introduce your host for today's program, Melissa Jarrell, Executive 00:00:33.731 -- 00:00:36.474 Director of Legal at Heron. Please go ahead. 00:00:36.474 -- 00:00:38.474 Thank 00:00:39.096 -- 00:00:43.660 you, operator, and hello, everyone. Thank you for joining us on the Heron Therapeutics 00:00:43.660 -- 00:00:47.884 Conference call today to discuss the company's financial results for the quarter ended 00:00:47.884 -- 00:00:50.345 June 30th, 2025. 00:00:50.787 -- 00:00:56.185 With me today from Heron are Craig Collard, Chief Executive Officer, Ira Duarte, Executive 00:00:56.185 -- 00:01:00.813 Vice President, Chief Financial Officer, Bill Forbes, Executive Vice President, Chief 00:01:00.813 -- 00:01:05.961 Development Officer, Mark Hensley, Chief Operating Officer, and Kevin Warner, Senior 00:01:05.961 -- 00:01:09.668 Vice President, Medical Affairs, Strategy, and Engagement. 00:01:09.668 -- 00:01:13.734 For those of you participating via conference call, slides are made available via webcast 00:01:13.734 -- 00:01:17.881 and can also be accessed via...